Location History:
- Tompkins, NY (US) (1998)
- Tempe, AZ (US) (2004)
- Gold Canyon, NY (US) (2009)
- Superstition Mountain, AZ (US) (2008 - 2011)
- Ithaca, NY (US) (2001 - 2012)
- Gold Canyon, AZ (US) (2013 - 2018)
Company Filing History:
9 out of 1,736 
6 out of 297 
5 out of 66 
Years Active: 1998-2018
As an assistant focused on innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide information about inventor Charles Joel Arntzen based on the data provided.
Title: Exploring the Innovations of Charles Joel Arntzen
Introduction: Charles Joel Arntzen is a prolific inventor based in Ithaca, NY, with an impressive track record of 26 patents to his name. His groundbreaking work has notably advanced plant transient expression technology and immune response elicitation methods.
Latest Patents:
1. Geminiviral Vector for Expression of Rituximab: Arntzen's innovative patent describes a novel system utilizing a single vector or multiple separate vectors for optimizing the expression of Rituximab in plant cells. This advancement eliminates the need for non-competing viruses, enhancing the commercial viability of producing Rituximab.
2. Methods and Compositions Related to Glycoprotein-Immunoglobulin Fusions: Arntzen's patent focuses on compositions and methods for eliciting immune responses against HCV antigens, specifically targeting HCV glycoproteins E1 and E2. This work represents a significant contribution to the field of immunology.
Career Highlights: Arntzen has contributed his expertise to esteemed organizations such as the Research Development Foundation and the Boyce Thompson Institute for Plant Research. His dedication to innovation has led to transformative developments in plant biotechnology and immunology.
Collaborations: Throughout his career, Arntzen has collaborated with notable professionals in the field, including Hugh S Mason and Jordan U Gutterman. These collaborations have enriched his work and propelled advancements in plant-based pharmaceutical production and immune system research.
Conclusion: Charles Joel Arntzen's pioneering work in plant expression technology and immunology has left an indelible mark on the scientific community. His patents stand as a testament to his innovative spirit and commitment to pushing the boundaries of what is possible in biotechnology and healthcare.